Turtle Cameron
Spyre Therapeutics, Inc. ยท Chief Executive Officer
Turtle Cameron is listed in public filings as director, officer: Chief Executive Officer. This Turtle Cameron insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Spyre Therapeutics, Inc. (SYRE), Damora Therapeutics, Inc. (DMRA), and Oruka Therapeutics, Inc. (ORKA). Investors use Turtle Cameron's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $42M600.8k shares | SellJun 1, 2026 | $574.5K8.1k shares | $70.50 | -- | |
| $42M609k shares | SellJun 1, 2026 | $246.9K3.6k shares | $69.40 | -- | |
| $43M597.5k shares | SellJun 1, 2026 | $235.1K3.3k shares | $71.38 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $43M622.2k shares | SellMay 1, 2026 | $368.6K5.3k shares | $69.54 | -- | |
| $44M618.6k shares | SellMay 1, 2026 | $254.8K3.6k shares | $70.77 | -- | |
| $45M614.5k shares | SellMay 1, 2026 | $226.7K3.1k shares | $73.14 | -- | |
| $45M612.8k shares | SellMay 1, 2026 | $126.2K1.7k shares | $74.23 | -- | |
| $44M617.6k shares | SellMay 1, 2026 | $71.8K1k shares | $71.76 | -- | |
| $46M612.5k shares | SellMay 1, 2026 | $22.5K300 shares | $74.96 | -- | |
| $31M630.2k shares | SellApr 1, 2026 | $607.3K12.3k shares | $49.20 | -- | |
| $31M627.5k shares | SellApr 1, 2026 | $132.6K2.7k shares | $49.92 | -- | |
| $860k37.3k shares | Grant / ExerciseMar 23, 2026 | $860.1K37.3k shares | $23.05 | -- | |
| $27M642.5k shares | SellMar 2, 2026 | $386.7K9.1k shares | $42.49 | -- | |
| $27M651.6k shares | SellMar 2, 2026 | $246.2K5.9k shares | $41.73 | -- | |
| $22M657.5k shares | SellFeb 2, 2026 | $461.6K14k shares | $32.87 | -- | |
| $21M671.6k shares | SellFeb 2, 2026 | $30.5K957 shares | $31.82 | -- | |
| $16M528k shares | Grant / ExerciseJan 9, 2026 | $16.2M528k shares | $30.61 | -- | |
| $21M674.2k shares | SellJan 2, 2026 | $387.2K12.7k shares | $30.47 | -- | |
| $22M671.9k shares | SellJan 2, 2026 | $3.2K100 shares | $32.39 | -- | |
| $21M672k shares | SellJan 2, 2026 | $69.7K2.2k shares | $31.79 | -- | |
| $20M690.9k shares | SellDec 1, 2025 | $315.9K11k shares | $28.73 | -- | |
| $20M686.9k shares | SellDec 1, 2025 | $119.5K4k shares | $29.83 | -- | |
| $17M718.8k shares | SellNov 3, 2025 | $651.2K28.2k shares | $23.13 | -- | |
| $17M701.9k shares | SellNov 3, 2025 | $398.6K16.8k shares | $23.66 | -- | |
| $206k17.5k shares | Grant / ExerciseJun 2, 2025 | $206.0K17.5k shares | $11.77 | -- | |
| $8.0M370k shares | Grant / ExerciseJan 15, 2025 | $8.0M370k shares | $21.66 | -- |